In this video interview, SeraCare’s Chief Scientific Officer Dr. Russell Garlick shares some background about SeraCare’s history of manufacturing controls and reference materials for infectious disease diagnostics, and how advances in Precision Medicine reveal a need for similar materials for the fields of oncology and maternal health.
Dr. Garlick has worked on the development, regulatory approval and launch of a variety of technologies and assays, having co-founded Life Sciences Group and having held executive positions at PerkinElmer Life Sciences and DuPont NEN Life Sciences.
For more information about our new Seraseq precision medicine products, click here.
